Systematic review of antimicrobial resistance among Gram positive cocci in hospitals in Colombia
Keywords:
Drug resistance, microbial, microbial sensitivity tests, health surveillance, Staphylococcus, Enterococcus
Abstract
Introduction. Bacterial resistance is a public health problem worldwide whose proper management requires knowledge of its presence and its behavior in each region and country.Objectives. A survey of the medical literature was conducted to identify levels of resistance to antibiotic markers in Gram positive bacterial isolates from Colombian hospitals.
Materials and methods. A systematic review of the literature included articles indexed in MEDLINE and LILACS. A manual search was made of Colombian scientific journals and other infectious disease literature not available electronically.
Results. A total of 34 observational studies were located, including a series of consecutive reports initiated in 2001. Most of the reports came from the city of Bogota. The rate of methicillin resistance for Staphylococcus aureus and coagulase-negative staphylococci in non intensive care unit isolates ranged between 35%-50% and 72%-76%, respectively. Resistance in intensive care unit isolates had a range between 35%-71% and 74%-83%, respectively. The rate of vancomycin-resistant Enterococcus faecium averaged less than 20% over the years but with large annual variation .
Conclusions. Resistance markers appeared in high frequency among Gram positive isolates identified in hospitals in major Colombian cities.
Downloads
Download data is not yet available.
References
1. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control. 2006;34:S3-10.
2. Kaye KS, Engemann JJ, Fraimow HS y Abrutyn E. Pathogens resistant to antimicrobial agents: Epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am. 2004;18:467-511.
3. Rybak MJ. Pharmacodynamics: Relation to antimicrobial resistance. Am J Infect Control. 2006;34:S38-45.
4. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Infect Control. 2006;34:S11-9.
5. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions 4.2.6. Fecha de consulta: 6 de octubre de 2006. Disponible en: http://www.cochrane.org/resources/handbook/hbook.htm.
6. Leal AL, Eslava-Schmalbach J, Álvarez C, Buitrago G, Méndez M. Endemic tendencies and bacterial resistance markers in third-level hospitals in Bogota, Colombia. Rev Salud Pública (Bogotá). 2006;8(Suppl.1):59-70.
7. Arias CA, Reyes J, Zúniga M, Cortés L, Cruz C, Rico CL, et al. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother. 2003;51:59-68.
8. Vesga O, Toro JM. Sepsis por Staphylococcus aureus. Acta Med Colomb. 1994;19:116-24.
9. Álvarez C, Cortés J, Arango A, Correa C, Leal A. Anti-microbial resistance in intensive care units in Bogotá, Colombia, 2001-2003. Rev Salud Pública (Bogotá). 2006;8(Suppl.1):86-101.
10. Cortés JA, Gómez CA, Cuervo SI, Leal AL. Community-acquired methicillin-resistant Staphylococcus aureus in Bogotá, Colombia: Public health implications. Rev Salud Pública (Bogotá). 2007;9:448-54.
11. Robledo J, López J, Sierra P, Vesga O, Pfaller M. El programa de vigilancia antimicrobiana SENTRY en Colombia, hallazgos iniciales en tres hospitales de Medellín. Infectio. 1999;3:448-54.
12. Reyes J, Hidalgo M, Díaz L, Rincón S, Moreno J, Vanegas N, et al. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: A countrywide surveillance. Int J Infect Dis. 2007;11:329-36.
13. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145:582-91.
14. Hidalgo M, Reyes J, Cárdenas AM, Díaz L, Rincón S, Vanegas N, et al. Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci. Biomédica. 2008;28:284-94.
15. Jaramillo EL. Resistencia bacteriana a los antibióticos en la Unidad de Cuidados Intensivos, Hospital de Caldas, 1992-1994. Colombia Médica. 1996;27:69-76.
16. Secretaría de Salud de Bogotá. Boletín epidemiológico distrital de infecciones intrahospitalarias 2007. Bogotá D.C.: Secretaría de Salud de Bogotá; 2007. p. 1-15.
17. Grupo para el Control de la Resistencia Bacteriana GREBO. Boletín informativo GREBO 2008. Bogotá D.C.: Gráficas Ducal; 2008.
18. Martínez P, Mercado M, Mattar S. Actividad in vitro de moxifloxacina comparada con otros antibióticos frente a aislamientos nosocomiales de dos hospitales de Colombia. Universitas Medicas. 2004;45:101-9.
19. Pérez D, Mattar S, Mercado M. High resistance of nosocomial germs in Monteria, Colombia. Universitas Medicas. 2003;44:131-7.
20. Shorr AF. Epidemiology of staphylococcal resistance. Clin Infect Dis. 2007;45(Suppl.3):S171-6.
21. Amyes SG. Enterococci and streptococci. Int J Antimicrob Agents. 2007;29(Suppl.3):S43-52.
22. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77.
23. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29:996-1011.
24. Guzmán-Blanco M, Mejía C, Isturiz R, Álvarez C, Bavestrello L, Gotuzzo E, et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents. 2009;34:304-8.
25. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis. 2004;8:25-79.
26. Rodríguez-Noriega E, Seas C, Guzmán-Blanco M, Mejía C, Álvarez C, Bavestrello L, et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis. 2010;14:e560-6.
27. Livermore DM. Minimising antibiotic resistance. Lancet Infect Dis. 2005;5:450-9.
2. Kaye KS, Engemann JJ, Fraimow HS y Abrutyn E. Pathogens resistant to antimicrobial agents: Epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am. 2004;18:467-511.
3. Rybak MJ. Pharmacodynamics: Relation to antimicrobial resistance. Am J Infect Control. 2006;34:S38-45.
4. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Infect Control. 2006;34:S11-9.
5. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions 4.2.6. Fecha de consulta: 6 de octubre de 2006. Disponible en: http://www.cochrane.org/resources/handbook/hbook.htm.
6. Leal AL, Eslava-Schmalbach J, Álvarez C, Buitrago G, Méndez M. Endemic tendencies and bacterial resistance markers in third-level hospitals in Bogota, Colombia. Rev Salud Pública (Bogotá). 2006;8(Suppl.1):59-70.
7. Arias CA, Reyes J, Zúniga M, Cortés L, Cruz C, Rico CL, et al. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother. 2003;51:59-68.
8. Vesga O, Toro JM. Sepsis por Staphylococcus aureus. Acta Med Colomb. 1994;19:116-24.
9. Álvarez C, Cortés J, Arango A, Correa C, Leal A. Anti-microbial resistance in intensive care units in Bogotá, Colombia, 2001-2003. Rev Salud Pública (Bogotá). 2006;8(Suppl.1):86-101.
10. Cortés JA, Gómez CA, Cuervo SI, Leal AL. Community-acquired methicillin-resistant Staphylococcus aureus in Bogotá, Colombia: Public health implications. Rev Salud Pública (Bogotá). 2007;9:448-54.
11. Robledo J, López J, Sierra P, Vesga O, Pfaller M. El programa de vigilancia antimicrobiana SENTRY en Colombia, hallazgos iniciales en tres hospitales de Medellín. Infectio. 1999;3:448-54.
12. Reyes J, Hidalgo M, Díaz L, Rincón S, Moreno J, Vanegas N, et al. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: A countrywide surveillance. Int J Infect Dis. 2007;11:329-36.
13. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145:582-91.
14. Hidalgo M, Reyes J, Cárdenas AM, Díaz L, Rincón S, Vanegas N, et al. Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci. Biomédica. 2008;28:284-94.
15. Jaramillo EL. Resistencia bacteriana a los antibióticos en la Unidad de Cuidados Intensivos, Hospital de Caldas, 1992-1994. Colombia Médica. 1996;27:69-76.
16. Secretaría de Salud de Bogotá. Boletín epidemiológico distrital de infecciones intrahospitalarias 2007. Bogotá D.C.: Secretaría de Salud de Bogotá; 2007. p. 1-15.
17. Grupo para el Control de la Resistencia Bacteriana GREBO. Boletín informativo GREBO 2008. Bogotá D.C.: Gráficas Ducal; 2008.
18. Martínez P, Mercado M, Mattar S. Actividad in vitro de moxifloxacina comparada con otros antibióticos frente a aislamientos nosocomiales de dos hospitales de Colombia. Universitas Medicas. 2004;45:101-9.
19. Pérez D, Mattar S, Mercado M. High resistance of nosocomial germs in Monteria, Colombia. Universitas Medicas. 2003;44:131-7.
20. Shorr AF. Epidemiology of staphylococcal resistance. Clin Infect Dis. 2007;45(Suppl.3):S171-6.
21. Amyes SG. Enterococci and streptococci. Int J Antimicrob Agents. 2007;29(Suppl.3):S43-52.
22. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77.
23. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29:996-1011.
24. Guzmán-Blanco M, Mejía C, Isturiz R, Álvarez C, Bavestrello L, Gotuzzo E, et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents. 2009;34:304-8.
25. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis. 2004;8:25-79.
26. Rodríguez-Noriega E, Seas C, Guzmán-Blanco M, Mejía C, Álvarez C, Bavestrello L, et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis. 2010;14:e560-6.
27. Livermore DM. Minimising antibiotic resistance. Lancet Infect Dis. 2005;5:450-9.
How to Cite
1.
Espinosa CJ, Cortés JA, Castillo JS, Leal AL. Systematic review of antimicrobial resistance among Gram positive cocci in hospitals in Colombia. biomedica [Internet]. 2011 Apr. 16 [cited 2024 May 17];31(1):27-34. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/333
Some similar items:
- César A. Arias, Marylin Hidalgo, Jinnethe Reyes, Ana María Cárdenas, Lorena Díaz, Sandra Ríncon, Natasha Vanegas, Paula Lucía Díaz, Elizabeth Castañeda, Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci , Biomedica: Vol. 28 No. 2 (2008)
- Alfredo Prado, Nhora L. Arias, Mónica Chávez, Cristina E. Cabrera, Rómel F. Gómez, Phenotypic characterization of Acinetobacter baumannii isolates in a high-complexity healthcare institution in the city of Cali , Biomedica: Vol. 34 (2014): Abril, Suplemento 1, Resistencia bacteriana
- Leidy González, Jorge Alberto Cortés, Systematic review of antimicrobial resistance in Enterobacteriaceae isolates from Colombian hospitals , Biomedica: Vol. 34 No. 2 (2014)
- Manuel Medell, Marcia Hart, María Luisa Batista, In vitro antimicrobial susceptibility in Enterococcus faecalis and Enterococcus faecium isolated from hospitalized patients , Biomedica: Vol. 34 (2014): Abril, Suplemento 1, Resistencia bacteriana
- Sandra Rincón, Diana Panesso, Lorena Díaz, Lina P. Carvajal, Jinnethe Reyes, Jose M. Munita, Cesar Arias, Resistance to “last resort” antibiotics in Gram-positive cocci: The post-vancomycin era , Biomedica: Vol. 34 (2014): Abril, Suplemento 1, Resistencia bacteriana
- Johanna Marcela Vanegas, Luis Felipe Higuita, Carlos Andrés Vargas, Astrid Vanessa Cienfuegos, Erika Andrea Rodríguez, Gustavo Eduardo Roncancio, Judy Natalia Jiménez, Carbapenem-resistant Acinetobacter baumannii causing osteomyelitis and infections of skin and soft tissues in hospitals of Medellín, Colombia , Biomedica: Vol. 35 No. 4 (2015)
- Marcela López, Claudia Álvarez, Utility of nitrate reductase assay for detection of multidrug-resistant Mycobacterium tuberculosis in a low resource setting , Biomedica: Vol. 31 No. 2 (2011)
- Ana María Ocampo, Carlos Andrés Vargas, Patricia María Sierra, Astrid Vanessa Cienfuegos, Judy Natalia Jiménez, Molecular characterization of an outbreak of carbapenem-resistant Klebsiella pneumoniae in a tertiary care hospital in Medellín, Colombia , Biomedica: Vol. 35 No. 4 (2015)
- Virgilio Galvis, Alejandro Tello, Alfredo Guerra, María Fernanda Acuña, Donaldo Villarreal, Antibiotic susceptibility patterns of bacteria isolated from keratitis and intraocular infections at Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia , Biomedica: Vol. 34 (2014): Abril, Suplemento 1, Resistencia bacteriana
- Mercedes Figueroa, Armando Cortés, Álvaro Pazos, Luis Eduardo Bravo, Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis , Biomedica: Vol. 32 No. 1 (2012)
Issue
Section
Original articles
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
